tiprankstipranks
Acumen Pharmaceuticals (ABOS)
NASDAQ:ABOS
US Market

Acumen Pharmaceuticals (ABOS) Income Statement

Compare
416 Followers

Acumen Pharmaceuticals Income Statement

Last quarter (Q3 2024), Acumen Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Acumen Pharmaceuticals's net income was $-29.77M. See Acumen Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 1.44M
Gross Profit
$ 0.00$ -42.32M$ -169.00K$ -4.00K$ 1.43M
Operating Expenses
$ 114.02M$ 61.14M$ 45.24M$ 19.58M$ 9.35M
Depreciation and Amortization
$ 0.00$ 184.00K$ 169.00K$ 4.00K$ 7.91M
EBITDA
$ -114.02M$ -51.61M$ -42.69M$ 61.58M$ 587.00K
Operating Income
$ -114.02M$ -61.14M$ -45.24M$ 61.57M$ -7.91M
Other Income/Expenses
$ 11.69M$ 8.77M$ 2.38M$ -81.02M$ 587.00K
Pretax Income
$ -102.33M$ -52.37M$ -42.86M$ -100.61M$ -7.33M
Net Income
$ -102.33M$ -52.37M$ -40.48M$ -181.68M$ -7.32M
Per Share Metrics
Basic EPS
$ -1.71$ -1.08$ -1.00$ -4.49$ -0.18
Diluted EPS
$ -1.71$ -1.08$ -1.00$ -4.49$ -0.18
Weighted Average Shares Outstanding
60.01M 48.49M 40.60M 40.47M 40.15M
Weighted Average Shares Outstanding (Diluted)
60.01M 48.61M 40.60M 40.47M 40.15M
Currency in USD

Acumen Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis